FDA Inspection
EUGIA Pharma Specialities LimitedEUGIA Pharma Specialities Limited – FDA Inspection, Feb 27, 2026
Record Details
This FDA Inspection record concerns EUGIA Pharma Specialities Limited, with an inspection on February 27, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 7df17aa7-6253-487f-94ca-41e6ec737792
Inspection Facts
- Inspection number
- 1304662
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of EUGIA Pharma Specialities Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 26, 2023 | NAI | Drug Quality Assurance | |
| November 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 28, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| June 8, 2018 | Not classified | Office of Inspections and Investigations | |
| December 14, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for EUGIA Pharma Specialities Limited
- FDA Inspection 1234157 - 2023-07-26
- FDA Inspection 1234762 - 2022-11-25
- FDA Inspection 1100694 - 2019-08-28
- FDA Inspection 1057278 - 2018-06-08
- FDA Inspection 1039097 - 2017-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.